エレクトロポレーション機器の世界市場2020-2024

◆英語タイトル:Global Electroporation Instruments Market 2020-2024
◆商品コード:TNV20FB023
◆発行会社(リサーチ会社):Technavio
◆発行日:2019年12月27日
◆ページ数:120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

「エレクトロポレーション機器の世界市場2020-2024」は、エレクトロポレーション機器について市場概要、市場規模、エンドユーザー別(製薬企業およびバイオテクノロジー企業、学術研究機関、CRO)分析、顧客状況、地域状況、市場の要因・課題・トレンド、企業状況、企業分析などを総合的にまとめて調査・分析したものです。
・エグゼクティブサマリー
・市場概要
・市場規模
・ファイブフォース分析
・エレクトロポレーション機器の世界市場:エンドユーザー別(製薬企業およびバイオテクノロジー企業、学術研究機関、CRO)
・顧客状況
・地域状況
・市場の要因・課題・トレンド
・企業状況
・企業分析
【レポートの概要】

Global Electroporation Instruments Market 2020-2024
Technavio has been monitoring the global electroporation instruments market and it is poised to grow by USD 72.67 mn during 2020-2024, progressing at a CAGR of 7% during the forecast period. Our reports on electroporation instruments market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by rising demand for monoclonal antibodies. In addition, high demand for biopharmaceuticals is anticipated to boost the growth of the electroporation instruments market as well.

Market Segmentation

Technavio’s global electroporation instruments market is segmented as below:
End-user
• Pharma and biotech companies
• Academic and research institutes
• CROs

Geographic segmentation
• North America
• APAC
• Europe
• South America
• MEA

Key Trends for electroporation instruments market growth
This study identifies high demand for biopharmaceuticals as the prime reasons driving the electroporation instruments market growth during the next few years.

Prominent vendors in electroporation instruments market
We provide a detailed analysis of around 25 vendors operating in the electroporation instruments market, including some of the vendors such as BEX Co. Ltd., Bio-Rad Laboratories Inc., Celetrix LLC, Cellectricon AB, Eppendorf AG, Harvard Bioscience Inc., Lonza Group Ltd., MaxCyte Inc., Merck KGaA and Thermo Fisher Scientific Inc.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/Global-Electroporation-Instruments-Market-industry-analysis

About Technavio
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

1. Executive Summary
1. Market Overview
1. Market Landscape
1. Market ecosystem
2. Value chain analysis
1. Market Sizing
1. Market definition
2. Market segment analysis
3. Market size 2019
4. Market outlook: Forecast for 2019 – 2024
1. Five Forces Analysis
1. Five Forces Summary
2. Bargaining power of buyers
3. Bargaining power of suppliers
4. Threat of new entrants
5. Threat of substitutes
6. Threat of rivalry
7. Market condition
1. Market Segmentation by End-user
1. Market segments
2. Comparison by End user placement
3. Pharma and biotech companies – Market size and forecast 2019-2024
4. Academic and research institutes – Market size and forecast 2019-2024
5. CROs – Market size and forecast 2019-2024
6. Market opportunity by End user
1. Customer landscape
1. Overview
1. Geographic Landscape
1. Geographic segmentation
2. Geographic comparison
3. North America – Market size and forecast 2019-2024
4. Europe – Market size and forecast 2019-2024
5. APAC – Market size and forecast 2019-2024
6. South America – Market size and forecast 2019-2024
7. MEA – Market size and forecast 2019-2024
8. Key leading countries
9. Market opportunity by geography
1. Drivers, Challenges, and Trends
1. Market drivers
2. Volume driver – Demand led growth
3. Volume driver – Supply led growth
4. Volume driver – External factors
5. Volume driver – Demand shift in adjacent markets
6. Price driver – Inflation
7. Price driver – Shift from lower to higher priced units
8. Market challenges
9. Market trends
1. Vendor Landscape
1. Overview
2. Vendor landscape
3. Landscape disruption
1. Vendor Analysis
1. Vendors covered
2. Market positioning of vendors
3. BEX Co. Ltd.
4. Bio-Rad Laboratories Inc.
5. Celetrix LLC
6. Cellectricon AB
7. Eppendorf AG
8. Harvard Bioscience Inc.
9. Lonza Group Ltd.
10. MaxCyte Inc.
11. Merck KGaA
12. Thermo Fisher Scientific Inc.
1. Appendix
1. Scope of the report
2. Currency conversion rates for US$
3. Research methodology
4. List of abbreviations
Exhibits
1.Key Finding 1
2.Key Finding 2
3.Key Finding 3
4.Key Finding 4
5.Key Finding 5
6.Key Finding 6
7.Key Finding 7
8.Market in focus
9.Parent market
10.Market characteristics
11.Product / Service portfolio of key vendors included in the market definition
12.Market segments
13.Global – Market size and forecast 2019 – 2024 ($ million)
14.Global market: Year-over-year growth 2019 – 2024 (%)
15.Five forces analysis 2019 & 2024
16.Bargaining power of buyers
17.Bargaining power of suppliers
18.Threat of new entrants
19.Threat of substitutes
20.Threat of rivalry
21.Market condition – Five forces 2019
22.End user placement – Market share 2019-2024 (%)
23.Comparison by End user placement
24.Pharma and biotech companies – Market size and forecast 2019-2024 ($ million)
25.Pharma and biotech companies – Year-over-year growth 2019-2024 (%)
26.Academic and research institutes – Market size and forecast 2019-2024 ($ million)
27.Academic and research institutes – Year-over-year growth 2019-2024 (%)
28.CROs – Market size and forecast 2019-2024 ($ million)
29.CROs – Year-over-year growth 2019-2024 (%)
30. Market opportunity by End user
31.Customer landscape
32.Market share by geography 2019-2024 (%)
33.Geographic comparison
34.North America – Market size and forecast 2019-2024 ($ million)
35.North America – Year-over-year growth 2019-2024 (%)
36.Europe – Market size and forecast 2019-2024 ($ million)
37.Europe – Year-over-year growth 2019-2024 (%)
38.APAC – Market size and forecast 2019-2024 ($ million)
39.APAC – Year-over-year growth 2019-2024 (%)
40.South America – Market size and forecast 2019-2024 ($ million)
41.South America – Year-over-year growth 2019-2024 (%)
42.MEA – Market size and forecast 2019-2024 ($ million)
43.MEA – Year-over-year growth 2019-2024 (%)
44.Key leading countries
45.Market opportunity by geography ($ million)
46.Impact of drivers
47.Impact of challenges
48.Landscape disruption
49.Industry risks
50.Vendors covered
51.Market positioning of vendors
52.BEX Co. Ltd. – Overview (1/3)
53.BEX Co. Ltd. – Overview (2/3)
54.BEX Co. Ltd. – Overview (3/3)
55.BEX Co. Ltd. – Product and service
56.BEX Co. Ltd. – Key offerings
57.BEX Co. Ltd. – Key customers
58.BEX Co. Ltd. – Segment focus
59.Bio-Rad Laboratories Inc. – Overview (1/3)
60.Bio-Rad Laboratories Inc. – Overview (2/3)
61.Bio-Rad Laboratories Inc. – Overview (3/3)
62.Bio-Rad Laboratories Inc. – Business segments
63.Bio-Rad Laboratories Inc. – Key offerings
64.Bio-Rad Laboratories Inc. – Key customers
65.Bio-Rad Laboratories Inc. – Segment focus
66.Celetrix LLC – Overview (1/3)
67.Celetrix LLC – Overview (2/3)
68.Celetrix LLC – Overview (3/3)
69.Celetrix LLC – Product and service
70.Celetrix LLC – Key offerings
71.Celetrix LLC – Key customers
72.Celetrix LLC – Segment focus
73.Cellectricon AB – Overview (1/3)
74.Cellectricon AB – Overview (2/3)
75.Cellectricon AB – Overview (3/3)
76.Cellectricon AB – Product and service
77.Cellectricon AB – Key offerings
78.Cellectricon AB – Key customers
79.Cellectricon AB – Segment focus
80.Eppendorf AG – Overview (1/3)
81.Eppendorf AG – Overview (2/3)
82.Eppendorf AG – Overview (3/3)
83.Eppendorf AG – Product and service
84.Eppendorf AG – Key offerings
85.Eppendorf AG – Key customers
86.Eppendorf AG – Segment focus
87.Harvard Bioscience Inc. – Overview (1/3)
88.Harvard Bioscience Inc. – Overview (2/3)
89.Harvard Bioscience Inc. – Overview (3/3)
90.Harvard Bioscience Inc. – Business segments
91.Harvard Bioscience Inc. – Key offerings
92.Harvard Bioscience Inc. – Key customers
93.Harvard Bioscience Inc. – Segment focus
94.Lonza Group Ltd. – Overview (1/3)
95.Lonza Group Ltd. – Overview (2/3)
96.Lonza Group Ltd. – Overview (3/3)
97.Lonza Group Ltd. – Business segments
98.Lonza Group Ltd. – Key offerings
99.Lonza Group Ltd. – Key customers
100.Lonza Group Ltd. – Segment focus
101.MaxCyte Inc. – Overview (1/3)
102.MaxCyte Inc. – Overview (2/3)
103.MaxCyte Inc. – Overview (3/3)
104.MaxCyte Inc. – Business segments
105.MaxCyte Inc. – Key offerings
106.MaxCyte Inc. – Key customers
107.MaxCyte Inc. – Segment focus
108.Merck KGaA – Overview (1/3)
109.Merck KGaA – Overview (2/3)
110.Merck KGaA – Overview (3/3)
111.Merck KGaA – Business segments
112.Merck KGaA – Key offerings
113.Merck KGaA – Key customers
114.Merck KGaA – Segment focus
115.Thermo Fisher Scientific Inc. – Overview (1/3)
116.Thermo Fisher Scientific Inc. – Overview (2/3)
117.Thermo Fisher Scientific Inc. – Overview (3/3)
118.Thermo Fisher Scientific Inc. – Business segments
119.Thermo Fisher Scientific Inc. – Key offerings
120.Thermo Fisher Scientific Inc. – Key customers
121.Thermo Fisher Scientific Inc. – Segment focus
122.Currency conversion rates for US$
123.Research Methodology
124.Validation techniques employed for market sizing
125.Information sources
126.List of abbreviations



【掲載企業】

BEX Co. Ltd.
Bio-Rad Laboratories Inc.
Celetrix LLC
Cellectricon AB
Eppendorf AG
Harvard Bioscience Inc.
Lonza Group Ltd.
MaxCyte Inc.
Merck KGaA
Thermo Fisher Scientific Inc.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[エレクトロポレーション機器の世界市場2020-2024]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆